这些发现表明测定肿瘤细胞内这两类蛋白的水平可帮助预测患者对微管蛋白抑制剂抗癌药的治疗效果。
Their findings suggest that testing tumor cells for levels of these proteins could help to predict patient response to antitubulin agents.
这些发现表明测定肿瘤细胞内这两类蛋白的水平可帮助预测患者对微管蛋白抑制剂抗癌药的治疗效果。
Their findings suggest that testing tumor cells for levels of these proteins could help to predict patient response to antitubulin agents.
应用推荐